More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.
A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.
The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.
Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.
The Food and Drug Administration has approved a new usage for a blood cancer drug,...
A biotechnology company will be acquired by one of the world's largest drug makers....
The Food and Drug Administration has approved a drug as an early treatment for a...
Stater Bros. is partnering with The Leukemia & Lymphoma Society for three weeks in June...